Skip to content

Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19

Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05063812
Acronym
RPM
Enrollment
18
Registered
2021-10-01
Start date
2020-09-21
Completion date
2023-12-31
Last updated
2024-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Infectious Disease, SARS-CoV Infection

Keywords

COVID-19, Emergency Medicine, Remote Patient Monitoring

Brief summary

The GW Medical Faculty Associates recently launched a remote monitoring program for patients diagnosed with COVID-19. Patients are provided with a home pulse oximeter and thermometer. Participants complete daily surveys about their symptoms and vital signs and are escalated to receive phone calls and video visits if responses are abnormal. Investigators would like to complete a study of the program to understand: 1. Operational parameters of program performance, such as how many patients were enrolled and how many patients completed monitoring 2. Clinical course of patients, including their reported symptoms over time and clinical endpoints such as hospitalization or ICU admission 3. Patient satisfaction with program

Detailed description

The SARS-CoV-2 that emerged in late 2019 has been noted to have a wide range of presentations, from asymptomatic and mild cases to those requiring intubation, ECMO, and critical care. As it is a novel pathogen, clinicians and scientists are only beginning understand when and who will require hospital-based resources such as oxygen, hospitalization, or ICU admission. The Medical Faculty Associates (MFA) COVID-19 Remote Monitoring Program (RPM) was developed to provide a daily touchpoint for patients during their COVID-19 course, including ready connection to paramedics and physicians when needed. The program was launched with the goal of identifying clinical decompensation early, maximizing available healthcare capacity, and minimizing nosocomial COVID-19 spread and healthcare worker exposure. Investigators would like to perform analyses to test multiple hypotheses, including: 1. Patients discharged with a diagnosis of COVID-19 will be able to participate in a remote monitoring program. 2. A COVID-19 remote monitoring program will benefit patients. 3. Patients will be satisfied with their experience of a remote monitoring program and will have lower anxiety about their COVID-19 illness.

Interventions

OTHERObservational

All these patients have been enrolled in the COVID-19 remote patient monitoring program

Sponsors

George Washington University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Laboratory-confirmed coronavirus infection * Age \>=18 * Primary language English or Spanish

Exclusion criteria

* Dementia * Pregnant \> 16 weeks gestation

Design outcomes

Primary

MeasureTime frameDescription
Patient unenrollment1 yearNumber of patients who unenrolled and for what reason
Patient referred1 yearNumber of patients referred
Patients enrolled1 yearNumber of patients enrolled
Response Rate1 yearPatients giving at least 50% response rate over 10 days
Flagged cases1 yearNumber of cases flagged for responses on survey
Telehealth1 yearNumber of cases escalated to telehealth
Patient program graduation1 yearNumber of patients who graduate from program

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026